Site notifications

Sub menu

 
 

Variations to prescription medicines: excluding variations requiring evaluation of clinical or bioequivalence data (for chemical entities)

Guidance about the types of notifications and variations for chemically derived (non-biological) prescription medicines.

Published
Last updated

Purpose

This guidance outlines the types of variations and changes that can be made to chemically derived (non-biological) prescription medicines currently on the Australian Register of Therapeutic Goods (ARTG). It is split into two parts:

  • Part 1: Corrections, notifications and quality information changes
  • Part 2: Product Information (PI) changes.

Legislation

Guidance

This guidance is presented as downloadable files because of its length. 

Downloads

Topics
Featured in

Page history

Show all page updates (5)

Migration to new 'Guidance' content type included changes to the following:

  • ‘Legislation’ section to clearly show which laws the Guidance relates to.
  • ‘Page history’ section replaces document version history.
  • New page navigation features.
  • New ‘Save as PDF’ feature.

Minor clarifications and corrections to:

  • API changes that do not require reporting to the TGA

CCSC: Container/closure system - changes to container components and/or dimensions.

Amended title

Inclusion of Extension of indications to align with a reference product

Additional information on:

  • variation types that are associated with a mandatory PAR field update
  • changes that do not need to be notified to the TGA
  • new variation types (including Associated changes and SARO).

Minor clarifications and corrections to phrasing and layout.

Inclusion of notifiable variations to registered medicines.

Minor amendments to phrasing and layout.
 

Original publication.

Migration to new 'Guidance' content type included changes to the following:

  • ‘Legislation’ section to clearly show which laws the Guidance relates to.
  • ‘Page history’ section replaces document version history.
  • New page navigation features.
  • New ‘Save as PDF’ feature.

Minor clarifications and corrections to:

  • API changes that do not require reporting to the TGA

CCSC: Container/closure system - changes to container components and/or dimensions.

Amended title

Inclusion of Extension of indications to align with a reference product

Additional information on:

  • variation types that are associated with a mandatory PAR field update
  • changes that do not need to be notified to the TGA
  • new variation types (including Associated changes and SARO).

Minor clarifications and corrections to phrasing and layout.

Inclusion of notifiable variations to registered medicines.

Minor amendments to phrasing and layout.
 

Original publication.

Related guidance

Help us improve the Therapeutic Goods Administration site